Voxar launches new 3-D version
Software developer Voxar has released its latest product offering, Plug ‘n View 3D version 3.0. Among the new features are OneClick segmentation and volume measurement, 2-D comparison, enhanced colon viewing, and 3-D movie capture. Enhanced
Software developer Voxar has released its latest product offering, Plug ‘n View 3D version 3.0. Among the new features are OneClick segmentation and volume measurement, 2-D comparison, enhanced colon viewing, and 3-D movie capture. Enhanced segmentation allows regions of bone and soft tissue to be identified, hidden, eliminated, or highlighted for 3-D analysis. Volume calculation enables clinicians to quantify and display the volume of tumors, lesions, or aneurysms for initial assessment and response to therapy. In colon viewing, side-by-side views of the prone and supine data sets are possible, as well as enhanced linking between 2-D axial images and 3-D views of the colonic wall, enhanced 3-D presets with simulated colonic wall coloring, simulated single-contrast barium enema, and simulated double-contrast barium enema.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
